Skip to main content

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Albert Lecube Torelló

Albert Lecube Torelló

Main researcher
Diabetes and Metabolism
Read more
Sara Valles Angulo

Sara Valles Angulo

Predoctoral researcher
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Nerea Castillo Flores

Nerea Castillo Flores

Postdoctoral researcher
Transfusional Medicine
Read more
Gladys Lorena Suárez Reynoso

Gladys Lorena Suárez Reynoso

Research assistant
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.